EMEA-001301-PIP02-12-M02

Key facts

Invented name
Cresemba
Active substance
Isavuconazonium (sulfate)
Therapeutic area
Infectious diseases
Decision number
P/0314/2018
PIP number
EMEA-001301-PIP02-12-M02
Pharmaceutical form(s)
  • Powder for solution for infusion
  • Capsule, hard
Condition(s) / indication(s)
  • Treatment of invasive aspergillosis
  • Treatment of mucormycosis
Route(s) of administration
  • Intravenous use
  • Oral use
Contact for public enquiries
Basilea Pharmaceutica International Ltd.

Tel. +41 616061400
E-mail: medical.information@basilea.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating
Average
1 rating